Nuvectra Corp
DelistedCIK 1648893fmd_0YJA5V4T2PYT2ZCQ7JJBFEJNEWManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 03, 2015 to Jun 30, 2019, 18 periods
Latest annual · FY2018
Millions- Total revenues
- 49
- Gross profit
- 26
- Operating income
- (43)
- Net income
- (48)
- Free cash flow
- (39)
Latest quarter · Q2 FY2019
Millions- Total revenues
- 12
- Gross profit
- 7
- Operating income
- (10)
- Net income
- (11)
- Free cash flow
- (12)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2015 to FY2018
- +110.5%
Nuvectra Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Revenue | $48.8 million | $27.1 million | +80.3% | 10-K 2019-03-04 · proof |
| Gross profit | $25.8 million | $12.7 million | +104.2% | 10-K 2019-03-04 · proof |
| Operating income | -$43.2 million | -$42.2 million | 10-K 2019-03-04 · proof | |
| Net income | -$48.1 million | -$44.6 million | 10-K 2019-03-04 · proof | |
| Cash from operating activities | -$38.7 million | -$48.2 million | 10-K 2019-03-04 · proof | |
| Free cash flow | -$39.4 million | -$49.4 million | 10-K 2019-03-04 · proof | |
| Total assets | $158 million | $91.1 million | +73.4% | 10-K 2019-03-04 · proof |
| Total liabilities | $65.1 million | $42.9 million | +51.7% | 10-K 2019-03-04 · proof |
| Cash and cash equivalents | $99.2 million | $28.2 million | +252.4% | 10-K 2019-03-04 · proof |
- What was Nuvectra Corp's revenue in fiscal 2018?
- Nuvectra Corp reported revenue of $48.8 million for fiscal 2018 (the year ended Dec 31, 2018), against $27.1 million the year before (+80.3%). Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What was Nuvectra Corp's gross profit in fiscal 2018?
- Nuvectra Corp reported gross profit of $25.8 million for fiscal 2018 (the year ended Dec 31, 2018), against $12.7 million the year before (+104.2%). Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What was Nuvectra Corp's operating income in fiscal 2018?
- Nuvectra Corp reported operating income of -$43.2 million for fiscal 2018 (the year ended Dec 31, 2018), against -$42.2 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What was Nuvectra Corp's net income in fiscal 2018?
- Nuvectra Corp reported net income of -$48.1 million for fiscal 2018 (the year ended Dec 31, 2018), against -$44.6 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What was Nuvectra Corp's cash from operating activities in fiscal 2018?
- Nuvectra Corp reported cash from operating activities of -$38.7 million for fiscal 2018 (the year ended Dec 31, 2018), against -$48.2 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What was Nuvectra Corp's free cash flow in fiscal 2018?
- Nuvectra Corp reported free cash flow of -$39.4 million for fiscal 2018 (the year ended Dec 31, 2018), against -$49.4 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What are Nuvectra Corp's total assets?
- As of Dec 31, 2018, Nuvectra Corp reported total assets of $158 million, against $91.1 million a year earlier (+73.4%). Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What are Nuvectra Corp's total liabilities?
- As of Dec 31, 2018, Nuvectra Corp reported total liabilities of $65.1 million, against $42.9 million a year earlier (+51.7%). Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
- What are Nuvectra Corp's cash and cash equivalents?
- As of Dec 31, 2018, Nuvectra Corp reported cash and cash equivalents of $99.2 million, against $28.2 million a year earlier (+252.4%). Source: the 10-K filed with the SEC on Mar 4, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1648893&period_type=annual&limit=5"Information only, not investment advice.